πŸ‡ΊπŸ‡Έ FDA
Patent

US 12403137

Compounds and methods of use

granted A61KA61K31/4725A61K31/496

Quick answer

US patent 12403137 (Compounds and methods of use) held by Tango Therapeutics, Inc. expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Tango Therapeutics, Inc.
Grant date
Tue Sep 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/4725, A61K31/496, A61K31/506, A61K31/5377